Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-11-02

FDA Approved: KETOROLAC TROMETHAMINE — Original Application (Alembic Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved Alembic Pharmaceuticals Inc.'s original application for ketorolac tromethamine, enabling a generic version of this NSAID analgesic. The product is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketorolac tromethamine (Ketorolac tromethamine)

Snippet

ORIG AP for KETOROLAC TROMETHAMINE (KETOROLAC TROMETHAMINE)